SCHEMBL16404706

SCHEMBL16404706

OSc1cccc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577210 0.79 ACHE (0.46)
SCHEMBL482240 0.79 HAO1 (0.55)
SCHEMBL1615865 0.77
SCHEMBL11200483 0.77
SCHEMBL25416404 0.76 KDM4E (0.41)
SCHEMBL776328 0.75
SCHEMBL31325156 0.75
SCHEMBL10940299 0.75
SCHEMBL1145703 0.75
SCHEMBL19042227 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3409278-B1 HETEROCYCLIC PROTEIN KINASE INHIBITORS TOLERO PHARMACEUTICALS INC (US) 2020-09-16 EP disclosed
WO-2018030466-A1 HETEROCYCLIC COMPOUND 武田薬品工業株式会社 2018-02-15 WO disclosed
WO-2017097215-A1 WNT PATHWAY INHIBITOR EMBEDDED WITH UREAS STRUCTURE 杭州雷索药业有限公司 2017-06-15 WO disclosed
WO-2017021805-A1 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS PFIZER INC. (US) 2017-02-09 WO disclosed
EP-2826826-A1 Composition for forming a coating type BPSG film, substrate formed a film by said composition, and patterning process using said composition Shin-Etsu Chemical Co., Ltd. (JP) 2015-01-21 EP disclosed